Most Read Articles
Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
Tristan Manalac, 11 Jan 2019
Less than 15 percent of Singaporean adolescents get the recommended 8–10 hours of sleep on a school night, reports a recent study, noting that such short sleep duration is linked to symptoms of depression, overweight or obesity, and poorer self-rated health.
04 Jan 2019
Obstructive sleep apnoea may increase the risk of male-pattern baldness in men with a family history of hair loss, and this association appears to be mediated by low serum transferrin saturation levels related to hypoxia, a study suggests.
6 days ago
Airway type 2 inflammation remains persistent in many asthmatics on inhaled corticosteroids, a new study has shown. These patients tend to be older and have a more severe disease.

VEGF-A levels predict outcome in ventilator-associated pneumonia

05 Jun 2018

Elevated levels of circulating vascular endothelial growth factor (VEGF)‐A are associated with early resolution of ventilator-associated pneumonia (VAP), regardless of disease severity, a study has found.

Researchers measured serum VEGF‐A levels for 7 consecutive days in 82 VAP patients. They also obtained bronchoalveolar lavage (BAL) samples from experimental mouse challenged intratracheally with Pseudomonas aeruginosa at the following time points: 24, 48 and 124 hours after bacterial challenge. Levels of VEGF‐A, tumour necrosis factor alpha (TNF‐α), interleukin (IL)‐1β, interferon‐gamma (IFNγ) and myeloperoxidase (MPO) activity were measured in the animal samples.

VEGF-A levels increased significantly on day 5. The increase was <45 percent in 36 patients and ≥45 percent in 46. Specifically, in the group of patients showing greater increase in VEGF-A levels, VAP resolution occurred with greater frequency (65.2 percent vs 36.1 percent; p=0.014) and earlier (p=0.005). These results were not pathogen-specific.

On logistic regression analysis, the likelihood of VAP resolution was threefold higher in patients with a more than 45-percent increase in VEGF-A levels on day 5 (odds ratio, 3.32; 95 percent CI, 1.33–8.25).

VEGF‐A levels in mouse BAL and lung tissue increased significantly at 124 hours. In mice pretreated with bevacizumab, VEGF‐A concentrations decreased whereas TNF‐α and MPO markedly increased.

The present data indicate that an early increase in circulating VEGF-A in patients with VAP is associated with a greater chance of a clinical resolution of disease, whereas animal experiments in mice show that levels of VEGF-A rise in parallel with the resolution of inflammation after bacterial infection. Additional clinical and mechanistic studies are needed to establish the role of VEGF-A in VAP resolution, researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
Tristan Manalac, 11 Jan 2019
Less than 15 percent of Singaporean adolescents get the recommended 8–10 hours of sleep on a school night, reports a recent study, noting that such short sleep duration is linked to symptoms of depression, overweight or obesity, and poorer self-rated health.
04 Jan 2019
Obstructive sleep apnoea may increase the risk of male-pattern baldness in men with a family history of hair loss, and this association appears to be mediated by low serum transferrin saturation levels related to hypoxia, a study suggests.
6 days ago
Airway type 2 inflammation remains persistent in many asthmatics on inhaled corticosteroids, a new study has shown. These patients tend to be older and have a more severe disease.